AVIV Trademark

Trademark Overview


On Friday, July 29, 2022, a trademark application was filed for AVIV with the United States Patent and Trademark Office. The USPTO has given the AVIV trademark a serial number of 97525656. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Thursday, February 1, 2024. This trademark is owned by AVIV PHARMA LLC. The AVIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations used to treat gastro-intestinal diseases and disorders, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmace...
aviv

General Information


Serial Number97525656
Word MarkAVIV
Filing DateFriday, July 29, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateThursday, February 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations used to treat gastro-intestinal diseases and disorders, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals; all of the foregoing for human use
Translation of Words in MarkThe English translation of "AVIV" in the mark is "SPRING".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAVIV PHARMA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLEWES, DE 19958

Trademark Events


Event DateEvent Description
Tuesday, August 2, 2022NEW APPLICATION ENTERED
Friday, August 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 17, 2023ASSIGNED TO EXAMINER
Wednesday, May 17, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 17, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 16, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 16, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 5, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 5, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, December 5, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 1, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, February 1, 2024PETITION TO REVIVE-GRANTED
Thursday, February 1, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, July 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 18, 2024ASSIGNED TO LIE